The progression of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
pandemic in Africa has so far been heterogeneous, and the full impact is not yet well understood…

The African continent like all other parts of the world with high infection/low vaccination
rates can, and will, be a source of novel SARS-CoV-2 variants. The A.23 viral lineage, …

Based on its predicted ability to affect transmissibility and pathogenesis, surveillance studies
have highlighted the role of a specific mutation (P681R) in the S1/S2 furin cleavage site of …

Control of HIV replication through CD4 + and CD8 + T cells might be possible, but the functional
and phenotypic characteristics of such cells are not defined. Among cytokines produced …

Human immunodeficiency virus (HIV) remains a public health threat, with drug resistance
being a major concern in HIV treatment. Next-generation sequencing (NGS) is a powerful tool …

HIV drug resistance (HIVDR) is of increasing health concern, especially among key
populations. We investigated the prevalence of virological suppression (VS), prevalence and …

Next-generation sequencing (NGS) enables reliable detection of resistance mutations in
minority variants of human immunodeficiency virus type 1 (HIV-1). There is paucity of evidence …

The progression of the SARS-CoV-2 pandemic in Africa has so far been heterogeneous
and the full impact is not yet well understood. Here, we describe the genomic epidemiology …

Background Identifying immunogens that induce HIV-1-specific immune responses is a
lengthy process that can benefit from computational methods, which predict T-cell epitopes for …

Here, we report SARS-CoV-2 genomic surveillance from March 2020 until January 2021 in
Uganda, a landlocked East African country with a population of approximately 40 million …